Prevalence of SARS-CoV-2 infection and impact of vaccination in dialysis patients over two years of the pandemic

Affiliations

• ¹ Faculty of Biomedical Sciences, Università della Svizzera italiana, 6900, Lugano, Switzerland.
• ² Clinical Trial Unit, Ente Ospedaliero Cantonale, 6900, Lugano, Switzerland.
• ³ Department of Intensive Care, Ente Ospedaliero Cantonale, 6900, Lugano, Switzerland.
• ⁴ Division of Pneumology, University Hospital of Geneva, 1200, Geneva, Switzerland.
• ⁵ Division of Nephrology, Ente Ospedaliero Cantonale, 6900, Lugano, Switzerland.
• ⁶ Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500, Bellinzona, Switzerland.
• ⁷ Department of Laboratory Medicine, Ente Ospedaliero Cantonale, 6500, Bellinzona, Switzerland.
• ⁸ Department of Medicine, Ente Ospedaliero Cantonale, 6500, Bellinzona, Switzerland.
• ⁹ Process Organization and Information Service, Ente Ospedaliero Cantonale, 6500, Bellinzona, Switzerland.
• ¹⁰ Clinical School, University of New South Wales, Sydney, 2052, Australia.
• ¹¹ Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, 6900, Lugano, Switzerland.
• ¹² Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, 8091, Zurich, Switzerland.
• ¹³ Faculty of Biomedical Sciences, Università della Svizzera italiana, 6900, Lugano, Switzerland. [email protected].
• ¹⁴ Department of Medicine, Ente Ospedaliero Cantonale, 6500, Bellinzona, Switzerland. [email protected].
• ¹⁵ Ospedale Regionale di Mendrisio, Via Turconi 23, CH-6850, Mendrisio, Switzerland. [email protected].